Chemokine receptor antagonists inhibit the entry of human immunodeficiency virus (HIV) into the host cell. Two chemokine receptors, CXCR4 and CCR5, are necessary for the virus to enter the cell, so by inhibiting these chemokine receptors the disease can be slowed.
Name | Updated |
---|---|
Maraviroc (Maraviroc [ ma-rav-i-rok ]) | 16-Aug-2023 |
Selzentry (Maraviroc [ ma-rav-i-rok ]) | 14-Jul-2023 |